Investor Relations
By helping our clients to consistently outperform and build a strong foundation for the future, Cowen aims to deliver long-term value for our shareholders.
FINANCIALS
Explore our SEC filings, corporate governance information and other shareholder information. Take a moment to read our latest Annual Report.
QUICK LINKS
- Annual Report
- Quarterly earnings
- Latest news
- Stock chart update
- Historical price lookup
- Stockholder services
- Analyst Coverage
- Investor Presentations
Stay up to date
GET IN TOUCH
Cowen Investor inquiries will be routed to J.T. Farley, Managing Director and Head of Investor Relations.
Stock Quote
COWN
Exchange NASDAQ (USD)
Price $34.65
Change -0.05 / -0.14%
Volume 539,421
Data as of 09/17/2021 4:00 PM UTC.
Minimum 15 minute delay.
News
News
Lycia Therapeutics Announces $70 Million Series B Financing Led by Redmile Group with Participation from Founding Investor Versant Ventures
Read the article “Lycia Therapeutics Announces $70 Million Series B Financing Led by Redmile Group with Participation from Founding Investor Versant Ventures”News
Obsidian Therapeutics Announces Closing of $115 Million Series B Financing
Read the article “Obsidian Therapeutics Announces Closing of $115 Million Series B Financing”News
John Patrick Miller Joins Cowen Research’s Washington Research Group to Cover ESG and Sustainability Policy
Read the article “John Patrick Miller Joins Cowen Research’s Washington Research Group to Cover ESG and Sustainability Policy”
